Pharvaris (NASDAQ:PHVS) Given Market Outperform Rating at JMP Securities

JMP Securities reissued their market outperform rating on shares of Pharvaris (NASDAQ:PHVS – Free Report) in a research note released on Wednesday, Benzinga reports. JMP Securities currently has a $49.00 price target on the stock. Several other equities analysts also recently issued reports on the stock. Wedbush decreased their price objective on shares of Pharvaris […]

Related Keywords

United States ,America , ,Tower Research Capital ,Qube Research Technologies Ltd ,America Corp ,Pharvaris Company Profile ,Schonfeld Strategic Advisors ,Morgan Stanley ,Free Report ,Research Capital ,Technologies Ltd ,Get Free Report ,Pharvaris Daily ,Pharvaris ,Nasdaq Phvs ,Phvs ,Medical ,Reiterated Rating ,Jmp Securities ,